Zhao-Qian Liu (Zhaoqian Liu)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Dna Damage Response

Top Venues

CNS neuroscience & therapeutics

Journal for immunotherapy of cancer

Advanced materials (Deerfield Beach, Fla.)

This page only lists publications with an associated author ORCID identifier.

Publications

Zhi-Bin Wang, Jun-Yan Liu, Shi-Long Jiang, Wei Zhuo, Pan Xie, Wen-Ting Dai, Xiao-Yuan Mao, Zhao-Qian Liu
Unveiling the shield: Troglitazone's impact on epilepsy-induced nerve injury through ferroptosis inhibition. CNS neuroscience & therapeutics 30 (8) (2024)
Mengrong Lei, Junyan Liu, Ying Gao, Wenting Dai, Hanxue Huang, Qingqing Jiang, Zhao-Qian Liu
DPP Inhibition Enhances the Efficacy of PD-1 Blockade by Remodeling the Tumor Microenvironment in Lewis Lung Carcinoma Model. Biomolecules 14 (4) (2024)
Juan Chen, Jia-Si Liu, Jun-Yan Liu, Lei She, Ting Zou, Fan Yang, Xiang-Ping Li, Zhan Wang, Zhao-Qian Liu
Plasma metabolomics of immune-related adverse events for patients with lung cancer treated with PD-1/PD-L1 inhibitors. Journal for immunotherapy of cancer 12 (7) (2024)
Zhi-Bin Wang, Jun-Yan Liu, Shi-Long Jiang, Wei Zhuo, Pan Xie, Wen-Ting Dai, Xiao-Yuan Mao, Zhao-Qian Liu
Unveiling the shield: Troglitazone's impact on epilepsy-induced nerve injury through ferroptosis inhibition. CNS neuroscience & therapeutics 30 (8) (2024)
Mengrong Lei, Junyan Liu, Ying Gao, Wenting Dai, Hanxue Huang, Qingqing Jiang, Zhao-Qian Liu
DPP Inhibition Enhances the Efficacy of PD-1 Blockade by Remodeling the Tumor Microenvironment in Lewis Lung Carcinoma Model. Biomolecules 14 (4) (2024)
Mengrong Lei, Junyan Liu, Ying Gao, Wenting Dai, Hanxue Huang, Qingqing Jiang, Zhao-Qian Liu
DPP Inhibition Enhances the Efficacy of PD-1 Blockade by Remodeling the Tumor Microenvironment in Lewis Lung Carcinoma Model. Biomolecules 14 (4) (2024)
Juan Chen, Jia-Si Liu, Jun-Yan Liu, Lei She, Ting Zou, Fan Yang, Xiang-Ping Li, Zhan Wang, Zhao-Qian Liu
Plasma metabolomics of immune-related adverse events for patients with lung cancer treated with PD-1/PD-L1 inhibitors. Journal for immunotherapy of cancer 12 (7) (2024)
Juan Chen, Jia-Si Liu, Jun-Yan Liu, Lei She, Ting Zou, Fan Yang, Xiang-Ping Li, Zhan Wang, Zhao-Qian Liu
Plasma metabolomics of immune-related adverse events for patients with lung cancer treated with PD-1/PD-L1 inhibitors. Journal for immunotherapy of cancer 12 (7) (2024)
Zhi-Bin Wang, Jun-Yan Liu, Shi-Long Jiang, Wei Zhuo, Pan Xie, Wen-Ting Dai, Xiao-Yuan Mao, Zhao-Qian Liu
Unveiling the shield: Troglitazone's impact on epilepsy-induced nerve injury through ferroptosis inhibition. CNS neuroscience & therapeutics 30 (8) (2024)
Feixiang Ding, Junyan Liu, Kelong Ai, Chun Xu, Xiaoyuan Mao, Zhao-Qian Liu, Haihua Xiao
Simultaneous Activation of Pyroptosis and cGAS-STING Pathway with Epigenetic/ Photodynamic Nanotheranostic for Enhanced Tumor Photoimmunotherapy. Advanced materials (Deerfield Beach, Fla.) (2023)
Chao Mei, Ze-En Sun, Li-Ming Tan, Jian-Ping Gong, Xi Li, Zhao-Qian Liu
eIF3a-PPP2R5A-mediated ATM/ATR dephosphorylation is essential for irinotecan-induced DNA damage response. Cell proliferation 55 (4) (2022)